Skip to content

Marjorie Taylor Greene discloses newest $250K investment

Marjorie Taylor Greene discloses newest $250K investment
Elmaz Sabovic

Not all U.S. politician stock traders are as savvy as Nancy Pelosi. Representative Marjorie Taylor Greene is a clear example of many mistimed trades, with the latest purchase of $250,000 worth of U.S. Treasury bills potentially potentially being another misstep.

Namely, on August 2, Greene disclosed an additional purchase of U.S. Treasury bills, having already bought $500,000 worth on July 24.

Greene's purchase of U.S. Treasury bills. Source: Quiver Quantitative
Greene’s purchase of U.S. Treasury bills. Source: Quiver Quantitative

The current yield of U.S. Treasury bills is 3.84%, which is among the lowest levels in 2024. It has been in a clear downward trend from just a week ago, when it stood at 4.2% and is far off from the peak of 4.7% on April 25.

U.S. Treasury bill yield in 2024. Source: Market Watch
U.S. Treasury bill yield in 2024. Source: Market Watch

Notably, the yield directly correlates with investors’ outlook on the overall economy. A higher yield is viewed as a better outlook than a negative one when the yield is lower.

Greene has mistimed other stock trades in 2024

Adding to the recent trend, Representative Marjorie Taylor Greene made an ill-timed investment in CrowdStrike (NASDAQ: CRWD) stock in late June. 

She reported the purchase on June 27, three days after acquiring the shares. Since then, CrowdStrike’s stock has plummeted 42%, reaching $222.05 at the time of reporting. 

This significant decline was primarily caused by a global computer outage linked to a faulty cybersecurity company update.

Moreover, looking at her most recent stock purchases, which she reported on July 24, out of six trades, only two have been in the green since, while some have recorded double-digit losses in less than two weeks.

Greene's stock purchases on July 24. Source: Quiver Quantitative
Greene’s stock purchases on July 24. Source: Quiver Quantitative

Greene recently claimed that she doesn’t trade stocks

According to her, Greene is an opponent of Congressional stock trading, as stated in an interview on January 3.

However, since then, the U.S. Representative has been notably active in stock trading; the Georgia Republican has made significant transactions in the first half of 2024, with reported stock purchases totaling $2.08 million and sales amounting to $65,000.

Buy stocks now with eToro – trusted and advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.